Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 14.47% is in line with its 5-year average of 15.32%, near the low end of its 5-year range (12.04%–20.39%).
As of the fiscal period ended Saturday, June 27, 2026. 3.60% below its 12-month average of 15.01%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
14.47%
NET PROFIT MARGIN AVG TTM
15.01%
NET PROFIT MARGIN AVG 3Y
15.18%
NET PROFIT MARGIN AVG 5Y
14.76%
NET PROFIT MARGIN AVG 10Y
14.07%
NET PROFIT MARGIN AVG 15Y
12.90%
NET PROFIT MARGIN AVG 20Y
11.70%
CURRENT VS TTM AVG
-3.60%
CURRENT VS 3Y AVG
-4.62%
CURRENT VS 5Y AVG
-1.94%
CURRENT VS 10Y AVG
+2.87%
CURRENT VS 15Y AVG
+12.24%
CURRENT VS 20Y AVG
+23.71%
SECTOR MEDIAN · HEALTHCARE
10.44%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+38.64%
vs the sector median at left
Thermo Fisher Scientific Inc.
Market Cap
$211.18B
Net Profit Margin
14.47%
TTM Avg
15.01%
3Y Avg
15.18%
5Y Avg
14.76%
Market Cap
$216.72B
Net Profit Margin
37.14%
TTM Avg
33.96%
3Y Avg
33.83%
5Y Avg
33.74%
Market Cap
$179.58B
Net Profit Margin
11.65%
TTM Avg
23.34%
3Y Avg
19.20%
5Y Avg
17.71%
Market Cap
$160.55B
Net Profit Margin
30.99%
TTM Avg
15.29%
3Y Avg
17.07%
5Y Avg
15.27%
Market Cap
$134.62B
Net Profit Margin
15.95%
TTM Avg
15.52%
3Y Avg
19.51%
5Y Avg
19.37%
Market Cap
$131.16B
Net Profit Margin
17.19%
TTM Avg
15.23%
3Y Avg
12.72%
5Y Avg
10.53%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $211.18B | 14.47% | 15.01% | 15.18% | 14.76% |
| Novo Nordisk A/S (NVO)vs › | $216.72B | 37.14% | 33.96% | 33.83% | 33.74% |
| Amgen Inc. (AMGN)vs › | $202.95B | 20.95% | 16.61% | 20.49% | 22.20% |
| Abbott Laboratories (ABT)vs › | $179.58B | 11.65% | 23.34% | 19.20% | 17.71% |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | 30.99% | 15.29% | 17.07% | 15.27% |
| Pfizer Inc. (PFE)vs › | $139.86B | 11.83% | 12.51% | 14.97% | 18.18% |
| CVS Health Corp. (CVS)vs › | $137.47B | 0.72% | 0.84% | 1.34% | 1.79% |
| Danaher Corporation (DHR)vs › | $134.62B | 15.95% | 15.52% | 19.51% | 19.37% |
| AstraZeneca PLC (AZN)vs › | $131.16B | 17.19% | 15.23% | 12.72% | 10.53% |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | 15.01% | -1.95% | 6.91% | 3.59% |
Operating Margin
17.7%
Net Profit Margin
14.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-27 | 14.47% |
| 2026-03-28 | 15.00% |
| 2025-12-31 | 16.17% |
| 2025-09-27 | 14.53% |
| 2025-06-28 | 14.90% |
| 2025-03-29 | 14.54% |
| 2024-12-31 | 16.06% |
| 2024-09-28 | 15.38% |
| 2024-06-29 | 14.69% |
| 2024-03-30 | 12.84% |
| 2023-12-31 | 14.97% |
| 2023-09-30 | 16.22% |
| 2023-07-01 | 12.74% |
| 2023-04-01 | 12.04% |
| 2022-12-31 | 13.76% |
| 2022-10-01 | 14.00% |
| 2022-07-02 | 15.17% |
| 2022-04-02 | 18.74% |
| 2021-12-31 | 15.49% |
| 2021-10-02 | 20.39% |
| 2021-07-03 | 19.71% |
| 2021-04-03 | 23.59% |
| 2020-12-31 | 23.68% |
| 2020-09-26 | 22.69% |
| 2020-06-27 | 16.71% |
| 2020-03-28 | 12.65% |
| 2019-12-31 | 14.67% |
| 2019-09-28 | 12.12% |
| 2019-06-29 | 17.72% |
| 2019-03-30 | 13.31% |
| 2018-12-31 | 13.80% |
| 2018-09-29 | 11.98% |
| 2018-06-30 | 12.37% |
| 2018-03-31 | 9.89% |
| 2017-12-31 | 8.73% |
| 2017-09-30 | 10.44% |
| 2017-07-01 | 12.26% |
| 2017-04-01 | 11.56% |
| 2016-12-31 | 12.71% |
| 2016-10-01 | 10.54% |
| 2016-07-02 | 11.39% |
| 2016-04-02 | 9.36% |
| 2015-12-31 | 12.95% |
| 2015-09-26 | 11.55% |
| 2015-06-27 | 11.98% |
| 2015-03-28 | 9.83% |
| 2014-12-31 | 13.38% |
| 2014-09-27 | 11.31% |
| 2014-06-28 | 6.44% |
| 2014-03-29 | 13.91% |
| 2013-12-31 | 9.87% |
| 2013-09-28 | 9.95% |
| 2013-06-29 | 8.56% |
| 2013-03-30 | 10.53% |
| 2012-12-31 | 11.55% |
| 2012-09-29 | 9.41% |
| 2012-06-30 | 7.52% |
| 2012-03-31 | 8.94% |
| 2011-12-31 | 9.22% |
| 2011-10-01 | 8.93% |
| 2011-07-02 | 18.06% |
| 2011-04-02 | 9.27% |
| 2010-12-31 | 10.70% |
| 2010-10-02 | 10.01% |
| 2010-07-03 | 8.96% |
| 2010-04-03 | 8.68% |
| 2009-12-31 | 9.63% |
| 2009-09-26 | 8.74% |
| 2009-06-27 | 8.33% |
| 2009-03-31 | 6.60% |
| 2008-12-31 | 10.97% |
| 2008-09-27 | 8.43% |
| 2008-06-28 | 9.21% |
| 2008-03-29 | 9.12% |
| 2007-12-31 | 9.15% |
| 2007-09-29 | 9.10% |
| 2007-06-30 | 6.87% |
| 2007-03-31 | 5.94% |
| 2006-12-31 | 1.52% |
| 2006-09-30 | 6.73% |
| 2006-07-01 | 6.71% |
| 2006-04-01 | 6.85% |
| 2005-12-31 | 7.61% |
| 2005-10-01 | 8.50% |
| 2005-07-02 | 9.21% |
| 2005-04-02 | 8.74% |
| 2004-12-31 | 19.74% |
| 2004-10-02 | 19.82% |
| 2004-07-03 | 17.34% |
| 2004-04-03 | 7.41% |
| 2003-12-31 | 10.61% |
| 2003-09-27 | 9.76% |
| 2003-06-28 | 10.29% |
| 2003-03-29 | 7.28% |
| 2002-12-31 | 15.32% |
| 2002-09-28 | 7.54% |
